April 2021 Simoa® Publications:
Neurology: MS and TBI
Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
Joisten N, et al.
Neurology® Neuroimmunology & Neuroinflammation. 2021;8
Multiple Sclerosis
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
Ferreira-Atuesta C, et al.
Frontiers in Neuroscience. 2021;15
Multiple Sclerosis
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event
Comabella M, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England). 2021:13524585211010082
Multiple Sclerosis
Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
Engel S, et al.
Therapeutic Advances in Neurological Disorders. 2021;14:17562864211001977
Multiple Sclerosis
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Fissolo N, et al.
Neurology® Neuroimmunology & Neuroinflammation. 2021;8
Multiple Sclerosis
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
Sjöbom U, et al.
JAMA network open. 2021;4:e214138
Traumatic Brain Injury
Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients-a PET/MR study
Marklund N, et al.
NeuroImage: Clinical. 2021:102665
Traumatic Brain Injury
Reducing acetylated tau is neuroprotective in brain injury
Shin MK, et al.
Cell. 2021
Traumatic Brain Injury
Neurotrauma Biomarker Levels and Adverse Symptoms Among Military and Law Enforcement Personnel Exposed to Occupational Overpressure Without Diagnosed Traumatic Brain Injury
Boutté AM, et al.
JAMA network open. 2021;4:e216445
Traumatic Brain Injury
April 2021 Simoa® Publications in Other Therapeutic Areas
